Decoy Therapeutics annual gross margin
2016
2017
2018
Decoy Therapeutics Gross Margin Growth & History (DCOY)
Decoy Therapeutics's gross margin was 77.93% for fiscal 2018.
View full Decoy Therapeutics company overviewDecoy Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | 77.93% | +17.67 pp |
| 2017 | 2017-12-31 | 60.26% | +25.83 pp |
| 2016 | 2016-12-31 | 34.42% | — |
Decoy Therapeutics quarterly gross margin
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2019 | 2019-06-30 | 95.96% | +69.26 pp |
| Q1 2019 | 2019-03-31 | 92.78% | +39.78 pp |
| Q4 2018 | 2018-12-31 | 54.05% | +1.19 pp |
| Q3 2018 | 2018-09-30 | 80.40% | +16.37 pp |
| Q2 2018 | 2018-06-30 | 26.70% | −29.98 pp |
| Q1 2018 | 2018-03-31 | 53.00% | −14.39 pp |
| Q4 2017 | 2017-12-31 | 52.85% | −2.41 pp |
| Q3 2017 | 2017-09-30 | 64.03% | +0.94 pp |
| Q2 2017 | 2017-06-30 | 56.69% | +55.13 pp |
| Q1 2017 | 2017-03-31 | 67.39% | — |
| Q4 2016 | 2016-12-31 | 55.27% | — |
| Q3 2016 | 2016-09-30 | 63.09% | — |
| Q2 2016 | 2016-06-30 | 1.56% | — |
Decoy Therapeutics gross margin trends
Between the periods ended 2016-12-31 and 2018-12-31, Decoy Therapeutics's gross margin increased from 34.42% to 77.93%, a change of +43.50 percentage points. The latest reported quarter, Q2 2019, shows 95.96%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Decoy Therapeutics source filings ↗